Dr. Barbara Pro, M.D.
Medical Oncology (Medical Oncology Physician)
- Medicare participating
At a glance
- Years since graduation
- 38
- In the NPI registry since
- 2006
- Medicare patients seen, 2024
- 74
Licensed in Texas since 1999, according to the Texas Medical Board. We show license dates only for the states that publish them in bulk; see which states do. For other states, check the state medical board.
The NPI date is when this clinician registered for a National Provider Identifier, the billing number used on health claims. It is not a license, graduation or board-certification date. NPIs were first issued in May 2005 and became required on claims in 2007–2008, so an early date usually means the clinician was already in practice before then. What an NPI is
Education and training
- 2006Registered with an NPI (national billing number; not a license date) — NPIs began in 2005, so practice likely started earlier
Medicare’s Care Compare data doesn’t list this clinician’s medical school. Undergraduate school, residency, fellowship, licensing exams and board certification aren’t in public federal data. Board certification can be confirmed with the certifying board (ABMS member boards for MDs, AOA boards for DOs).
Specialties and state licenses
-
Medical Oncology Physician primary
NY license 315256 · IL license 336100609 · PA license MD440349 · TX license K8432 (first issued 1999; canc non-renewal)
As reported to the NPI registry. To confirm a license is current, check the state medical board.
Where they work
Hospitals
- New York-Presbyterian Hospital New York, NY
Medical groups
- Trustees of Columbia University in The City of New York (2,296 clinicians)
Hospitals this clinician lists with Medicare, and groups they bill Medicare through (Care Compare). Affiliation doesn’t mean they see patients at every location.
Medicare patients and services
- Medicare patients, 2024
- 74
- Services billed
- 344
- Patients’ average age
- 74
| Service | Times | Patients |
|---|---|---|
| Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | 187 | 33 |
| Established patient office or other outpatient visit, 30-39 minutes | 73 | 23 |
| Established patient office or other outpatient visit, 40-54 minutes | 25 | 12 |
| Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | 21 | 11 |
| New patient office or other outpatient visit, 60-74 minutes | 15 | 15 |
| Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | 13 | 12 |
Medicare fee-for-service only. CMS leaves out services billed for fewer than 11 patients. These figures describe a practice’s Medicare work; they aren’t a measure of quality.
Payments from drug and device companies
In 2025, 2 companies reported 5 payments worth $4,567 in total to this clinician.
| Pfizer Inc. | $4,521 |
|---|---|
| Adaptive Biotechnologies Corporation | $45.64 |
| Consulting Fee | $4,320 |
|---|---|
| Food and Beverage | $247 |
What the payments were for
| Company | What it was for | Amount |
|---|---|---|
| Pfizer Inc. Aug 20, 2025 | Consulting Fee ADCETRIS · ONCOLOGY | $2,160 |
| Pfizer Inc. Aug 20, 2025 | Consulting Fee ADCETRIS · ONCOLOGY | $2,160 |
Each payment as the company reported it, with the products it named. Meals are counted in the totals above but not listed one by one.
From CMS Open Payments. A payment is not evidence of wrongdoing; many are for consulting, teaching or meals. Clinicians can review and dispute their records with CMS.